1. Home
  2. LZB vs NVAX Comparison

LZB vs NVAX Comparison

Compare LZB & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LZB
  • NVAX
  • Stock Information
  • Founded
  • LZB 1927
  • NVAX 1987
  • Country
  • LZB United States
  • NVAX United States
  • Employees
  • LZB N/A
  • NVAX N/A
  • Industry
  • LZB Home Furnishings
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LZB Consumer Discretionary
  • NVAX Health Care
  • Exchange
  • LZB Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • LZB 1.6B
  • NVAX 1.3B
  • IPO Year
  • LZB N/A
  • NVAX 1995
  • Fundamental
  • Price
  • LZB $41.97
  • NVAX $7.34
  • Analyst Decision
  • LZB Buy
  • NVAX Buy
  • Analyst Count
  • LZB 2
  • NVAX 5
  • Target Price
  • LZB $46.00
  • NVAX $19.00
  • AVG Volume (30 Days)
  • LZB 322.4K
  • NVAX 14.2M
  • Earning Date
  • LZB 06-16-2025
  • NVAX 05-08-2025
  • Dividend Yield
  • LZB 2.10%
  • NVAX N/A
  • EPS Growth
  • LZB 7.87
  • NVAX N/A
  • EPS
  • LZB 2.91
  • NVAX 2.97
  • Revenue
  • LZB $2,091,871,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • LZB $3.42
  • NVAX $40.01
  • Revenue Next Year
  • LZB $3.50
  • NVAX N/A
  • P/E Ratio
  • LZB $14.37
  • NVAX $2.47
  • Revenue Growth
  • LZB 1.80
  • NVAX 25.92
  • 52 Week Low
  • LZB $33.34
  • NVAX $5.01
  • 52 Week High
  • LZB $48.31
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • LZB 49.38
  • NVAX 55.86
  • Support Level
  • LZB $41.38
  • NVAX $6.84
  • Resistance Level
  • LZB $43.27
  • NVAX $7.62
  • Average True Range (ATR)
  • LZB 0.78
  • NVAX 0.55
  • MACD
  • LZB -0.24
  • NVAX 0.07
  • Stochastic Oscillator
  • LZB 8.68
  • NVAX 50.52

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; and Retail, which sells upholstered and case goods furniture to the end consumer. The majority of the company's revenue is derived from its Wholesale segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: